New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Amgen Inc. (AMGN) vs Sanofi (SNY)

Amgen Inc. and Sanofi are both Drug Manufacturers General companies. Amgen Inc. is the larger, with a market value of $237.4B against $111.3B — 2.1× the size. Sanofi trades at the lower P/E: 22.8× against 25.2×. Sanofi grew revenue faster over the last twelve months: 26.3% against 8.15%. Amgen Inc. has the higher net margin (24.1% vs 8.27%) and the higher return on invested capital (14.3% vs 7.05%). Both pay a dividend; Sanofi yields more (5.25% vs 2.84%). Across the 23 metrics below, Sanofi leads on 14 and Amgen Inc. on 9.

Valuation

Metric AMGN SNY Drug Manufacturers General median
P/E 25.25 22.80 25.26
P/S 6.10 1.87 3.43
P/B 16.54 1.37 5.10
Price to free cash flow 25.95 6.60 20.27
EV/EBITDA 16.22 11.23 13.94
EV/Sales 7.15 2.10 4.13
Earnings yield 3.96% 4.39% 2.53%
Free cash flow yield 3.85% 15.14% 4.50%

Profitability

Metric AMGN SNY Drug Manufacturers General median
Gross margin 70.90% 73.44% 73.01%
Operating margin 32.41% 18.73% 18.34%
Net margin 24.14% 8.27% 7.31%
Free cash flow margin 24.63% 40.26% 18.56%
Return on equity 78.35% 0.00% 20.02%
Return on assets 10.09% 3.24% 2.28%
Return on invested capital 14.29% 7.05% 6.26%

Growth

Metric AMGN SNY Drug Manufacturers General median
Revenue growth (TTM) 8.15% 26.32% 6.72%
EPS growth (last fiscal year) 88.23% 45.97% 21.81%
Revenue growth, 5-year CAGR 7.65% 4.37% 4.75%
Net income growth, 5-year CAGR 1.20% (8.87%) 0.00%

Health

Metric AMGN SNY Drug Manufacturers General median
Debt to equity 3.76 0.25 0.62
Current ratio 1.48 1.12 1.38
Net debt to EBITDA 2.94 0.76 1.15

Dividend

Metric AMGN SNY Drug Manufacturers General median
Dividend yield 2.84% 5.25% 2.44%
Payout ratio 0.72 1.20 0.61

Size

Metric AMGN SNY Drug Manufacturers General median
Market cap 237.36b 111.26b 121.75b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack